For reference: 15 mg · 5 mL · phosphate-buffered diluent.
I would like the arithmetic checked rather than the conclusion asserted.
I have deliberately not used an online calculator because I want to be able to check the result.
What is the general form of this calculation?
15 ÷ 5 = 3 mg/mL. Concentration is vial content divided by diluent volume, so 15 mg of peptide in 5 mL of phosphate-buffered diluent gives 3 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.03 mg — 30 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.
Add the diluent down the vial wall rather than directly onto the cake. Peptides are surface-active and shear at an air–liquid interface, so a jet of water into a lyophilised puck generates foam, and foam is aggregated protein at the interface, not just air.
Photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.
Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
The caveat is that this is not a recommendation to administer anything. Research-use-only material is not approved for human use.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThe distinction that resolves most of these questions is that bacteriostatic water suppresses microbial growth and does not sterilise anything. It buys you a multiple-withdrawal presentation; it does not make an unsterile preparation sterile, and it does not substitute for technique.
Tilting the vial to pool solution in the corner before the final draw, and giving it a minute to drain down the walls, genuinely recovers ten to twenty microlitres.
A 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide.
Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.
I would flag the obvious failure mode: people get the concentration right, get the volume right, and then read the syringe against the wrong scale.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
If the supplier documentation specifies a diluent, there is usually a reason, and if it specifies nothing, water for injection is the conservative default.
Write the arithmetic on the vial label. It costs nothing and removes the step where you reconstruct it from memory at an inconvenient moment.
On the detail: number of stopper piercings matters less than the gauge doing the piercing.
The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.
The caveat on all of this is that it assumes the vial contains what the label says.
Do the arithmetic twice, ideally with someone else doing it independently.
The relevant detail is that the dissolution time is a signal — if it is longer than expected, something went wrong in either the lyophilisation or the shipping.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.
The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.
Write the arithmetic on the vial label. It costs nothing and it removes the step where you reconstruct it from memory at an inconvenient moment.
Read the cake before you touch the vial. An intact, opaque, evenly distributed puck that sits proud of the vial base is what a good lyophilisation cycle produces. Anything else — collapse, melt-back at the stopper, a glassy film, a cake that has slumped to one side — is evidence about the cycle, the shipping, or both.
Check the barrel marking, not your memory of it.
One limitation: technique reduces risk, it does not remove it.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale against the barrel rather than against your assumption.
edited 30 May 2026 by Dr_Otto_Lindqvist — added the citation requested in comments
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.